In silico docking experiments demonstrated that lactoferrin could directly bind SARS-CoV-2 spike protein [3,4,67], while in vitro experiments showed its competition with the virus for ACE2 [69] and heparan sulfate proteoglycan binding, thus inhibiting the very early infection stage [10,66,69]. Here, ACE2 is linked to infection.